Despite changes to immunoregulatory B-cell phenotype, HDAC6 silencing or inhibition did not induce tumor-free survival in CLL-bearing mice, but rather delayed tumor progression. The gene discussed is HDAC6; the disease is B-cell chronic lymphocytic leukemia.